Vaccine Safety & Pharmacovigilance

Nasreen S, Jiang Y, Lu H, Lee A, Cutland CL, Gentile A, Giglio N, Macartney K, Deng L, Liu B, Sonneveld N. …Petousis-Harris H… Jeff Kwong Risk of Guillain-Barré syndrome after COVID-19 vaccination or SARS-CoV-2 infection: A multinational self-controlled case series study. Vaccine. 2025 Jul 11;60:127291.

Faksova K, Walsh D, Jiang Y, …Petousis-Harris H…et al. COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals. Vaccine 2024.

Phillips A, Jiang Y, Walsh D, …Petousis-Harris H…et al. Background rates of adverse events of special interest for COVID-19 vaccines: A multinational Global Vaccine Data Network (GVDN) analysis. Vaccine 2023; 41(42): 6227-38.

Phillips A, Jiang Y, Walsh D,…Petousis-Harris H… et al. Background rates of adverse events of special interest for COVID-19 vaccines: A multinational Global Vaccine Data Network (GVDN) analysis. Vaccine 2023; 41(42): 6227-38.

Dodd C, Andrews N, Petousis-Harris H, Sturkenboom M, Omer SB, Black S. Methodological frontiers in vaccine safety: qualifying available evidence for rare events, use of distributed data networks to monitor vaccine safety issues and monitoring the safety of pregnancy interventions. BMJ Global Health. 2021;6(Suppl 2):e003540. 

Petousis-Harris H. Assessing the safety of COVID-19 vaccines: a primer. Drug safety. 2020;43(12):1205-10. 

Petousis-Harris H, Dodd CN. (2020). Progress toward a global vaccine data network. Pediatric Infectious Disease Journal. 2020:39(11):1023-5.

Real-World Evidence (RWE)

Paynter J, Howe AS, Best E, Petousis-Harris H. A retrospective cohort study investigating the comparative effectiveness of pneumococcal vaccines against hospitalisation with otitis media and pneumonia in New Zealand. Vaccine. 2023;41(28):4121-8.

Duque J, Howe AS, Azziz‐Baumgartner E, Petousis‐Harris H. Multi‐decade national cohort identifies adverse pregnancy and birth outcomes associated with acute respiratory illness hospitalisations during the influenza season. Influenza and Other Respiratory Viruses. 2023;17(1):e13063.

Petousis-Harris H, Jiang Y, Yu L, Watson D, Walls T, Turner N, …Griffin JB. A retrospective cohort study of safety outcomes in New Zealand infants exposed to Tdap vaccine in utero. Vaccines. 2019;7(4):147. 

Petousis-Harris H, Howe AS, Paynter J, Turner N, Griffin J. Pneumococcal conjugate vaccines turning the tide on inequity: A retrospective cohort study of New Zealand children born 2006–2015. Clinical infectious diseases. 2019;68(5):818-26.

Paynter J, Goodyear-Smith F, Morgan J, Saxton P, Black S, Petousis-Harris H. Effectiveness of a Group B outer membrane vesicle meningococcal vaccine in preventing hospitalization from gonorrhea in New Zealand: A retrospective cohort study. Vaccines. 2019;7(1):31.

Griffin JB, Yu L, Watson D, Turner N, Walls T, Howe AS, Jiang Y, Petousis-Harris H. Pertussis Immunisation in Pregnancy Safety (PIPS) study: A retrospective cohort study of safety outcomes in pregnant women vaccinated with Tdap vaccine. Vaccine. 2018;36(34):5173-79.

Radke S, Petousis-Harris H, Watson D, Gentles D, Turner N. Age-specific effectiveness following each dose of acellular pertussis vaccine among infants and children in New Zealand. Vaccine. 2017;35(1):177-83.

Petousis-Harris H, Paynter J, Morgan J, Saxton P, McArdle B, Goodyear-Smith F, Black S. Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: A retrospective case-control study. The Lancet. 2017;390(10102):1603-10.

Petousis-Harris H, Walls T, Watson D, Paynter J, Graham P, Turner N. Safety of Tdap vaccine in pregnant women: An observational study. BMJ Open. 2016;6(4):e010911.

Immunisation Communication, Risk Interpretation & Confidence

Petousis-Harris H, Paynter J, Chisholm H, Batty K, Baker M, Tatley M. Robust Vaccine Safety Surveillance shows safety – we need to communicate this better. Public Health Expert Briefing. 19^th September 2024

Chan AHY, Tao M, Marsh S, Petousis-Harris H. Vaccine decision making in New Zealand: a discrete choice experiment. BMC Public Health 2024; 24(1): 1-11.

Crum AJ, Heathcote LC, Morrison Z, Yielder R, Leibowitz K, Petousis-Harris H, Thomas MG, Prober CG, Berek JS, Petrie KJ. Changing mindsets about side effects of the COVID-19 vaccination: A randomized controlled trial. Annals of Behavioral Medicine. 2023;Jun 6:kaad020.

Petousis-Harris H, Alley L. (2020) Impact of anti-vaccination campaigns on health worldwide. What lessons can Australia and the global community learn from this experience? Medical Journal of Australia. 2020;213(7).

Gauld N, Martin S, Sinclair O, Petousis-Harris H, Dumble F, Grant C. A qualitative study of views and experiences of women and health care professionals about free maternal vaccinations administered at community pharmacies. Vaccines. 2020;8(2):152.